Clinical Trial Update: The Effect of Allopurinol on the Risk of Cardiovascular Events in Patients with Cardiovascular Risk [Phase 3]

View source ↗

Summary

A Phase 3 trial is investigating whether allopurinol reduces cardiovascular events in patients with cardiovascular risk factors. The study status is currently r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases
• Hyperuricemia

Drugs mentioned

• Allopurinol (Allopurinol)

Snippet

Sponsor: Poznan University of Medical Sciences | Conditions: Cardiovascular Diseases, Uric Acid | Phase 3 | Status: RECRUITING